Citation 12177

BRANHAM,WS: DIAL,SL: MOLAND,CL: HASS,BS: BLAIR,RM: FANG,H: SHI,L: TONG,W: PERKINS,RG: SHEEHAN,DM:. (2002). PHYTOESTROGENS AND MYCOESTROGENS BIND TO THE RAT UTERINE ESTROGEN RECEPTOR.. 132(4)

Citation Details

Title	PHYTOESTROGENS AND MYCOESTROGENS BIND TO THE RAT UTERINE ESTROGEN RECEPTOR.
Authors	BRANHAM,WS: DIAL,SL: MOLAND,CL: HASS,BS: BLAIR,RM: FANG,H: SHI,L: TONG,W: PERKINS,RG: SHEEHAN,DM:
Year	2002
Volume	132
Issue	4

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-4'-6-TRIHYDROXY:	ACTIVE
2	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,4'-6-DIHYDROXY:	ACTIVE
3	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
4	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
5	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	WEAK ACTIVITY
6	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	WEAK ACTIVITY
7	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALEIN	EQUIVOCAL
8	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	EQUIVOCAL
9	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	WEAK ACTIVITY
10	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,6-HYDROXY:	INACTIVE
11	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,6-HYDROXY-2'-METHOXY:	INACTIVE
12	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	INACTIVE
13	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
14	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	INACTIVE
15	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-HYDROXY:	INACTIVE
16	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,(DL):	ACTIVE
17	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,4'-HYDROXY:	WEAK ACTIVITY
18	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,3'-HYDROXY:	WEAK ACTIVITY
19	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,6-HYDROXY:	EQUIVOCAL
20	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,7-HYDROXY:	EQUIVOCAL
21	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE	INACTIVE
22	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(DL):	INACTIVE
23	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
24	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGIN	INACTIVE
25	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	INACTIVE
26	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
27	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	EQUOL	ACTIVE
28	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN	ACTIVE
29	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,ISO: 3'-4'-7-TRIHYDROXY:	WEAK ACTIVITY
30	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	WEAK ACTIVITY
31	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PRUNETIN	EQUIVOCAL
32	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	EQUIVOCAL
33	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,ISO: 4'-6-7-TRIHYDROXY:	EQUIVOCAL
34	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTIN	INACTIVE
35	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	ACTIVE
36	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN,ISO:	ACTIVE
37	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,4'-HYDROXY:	WEAK ACTIVITY
38	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,4-HYDROXY:	WEAK ACTIVITY
39	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE	WEAK ACTIVITY
40	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMESTROL	ACTIVE
41	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPYRAN-2-ONE,1: 4-ETHYL-7-HYDROXY-3-(PARA-METHOXY-PHENYL)-DIHYDRO:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEARALENOL,ALPHA:	STRONG ACTIVITY
2	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEARALANOL,ALPHA:	STRONG ACTIVITY
3	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEARALANONE	STRONG ACTIVITY
4	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEARALANOL,BETA:	ACTIVE
5	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEARALENOL,BETA:	ACTIVE

Citation 12177

Citation Details

Summary

Organisms and Their Experiments (2)

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1